Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex – United States, March 2019 – December 2020

BACKGROUND: COVID-19 stay-at-home orders may reduce access to substance use treatment and naloxone, an opioid overdose reversal drug. The objective of this analysis was to compare monthly trends in pharmacy-based dispensing rates of medications for opioid use disorder (MOUD) (buprenorphine and exten...

Descripción completa

Detalles Bibliográficos
Autores principales: Cremer, Laura J., Board, Amy, Guy, Gery P., Schieber, Lyna, Asher, Alice, Parker, Erin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620097/
https://www.ncbi.nlm.nih.gov/pubmed/35065513
http://dx.doi.org/10.1016/j.drugalcdep.2021.109192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620097/
https://www.ncbi.nlm.nih.gov/pubmed/35065513
http://dx.doi.org/10.1016/j.drugalcdep.2021.109192

Ejemplares similares